Segment disclosures

Company overview

EASTMAN CHEMICAL CO

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

34 dimension combinations 673 retained observations 64 reported periods Partial retained history

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Additives And Functional Products

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=emn:AdditivesAndFunctionalProductsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30807000000 USD20260731Open filing evidence
2026-01-01 – 2026-06-301546000000 USD20260731Open filing evidence
2026-01-01 – 2026-03-31739000000 USD20260501Open filing evidence
2025-01-01 – 2025-12-312880000000 USD20260213Open filing evidence
2025-07-01 – 2025-09-30716000000 USD20251104Open filing evidence
2025-01-01 – 2025-09-302218000000 USD20251104Open filing evidence
2025-04-01 – 2025-06-30769000000 USD20260731Open filing evidence
2025-01-01 – 2025-06-301502000000 USD20260731Open filing evidence
2025-01-01 – 2025-03-31733000000 USD20260501Open filing evidence
2024-01-01 – 2024-12-312862000000 USD20260213Open filing evidence
2024-07-01 – 2024-09-30744000000 USD20251104Open filing evidence
2024-01-01 – 2024-09-302166000000 USD20251104Open filing evidence
2024-04-01 – 2024-06-30718000000 USD20250801Open filing evidence
2024-01-01 – 2024-06-301422000000 USD20250801Open filing evidence
2024-01-01 – 2024-03-31704000000 USD20250425Open filing evidence
2023-01-01 – 2023-12-312834000000 USD20260213Open filing evidence
2023-07-01 – 2023-09-30670000000 USD20241101Open filing evidence
2023-01-01 – 2023-09-302194000000 USD20241101Open filing evidence
2023-04-01 – 2023-06-30747000000 USD20240726Open filing evidence
2023-01-01 – 2023-06-301524000000 USD20240726Open filing evidence
2023-01-01 – 2023-03-31777000000 USD20230428Open filing evidence
2022-01-01 – 2022-12-313475000000 USD20250214Open filing evidence
2022-04-01 – 2022-06-30924000000 RestatedUSD20230728Open filing evidence
2022-01-01 – 2022-06-301813000000 RestatedUSD20230728Open filing evidence
2022-01-01 – 2022-03-31889000000 RestatedUSD20230428Open filing evidence
2021-04-01 – 2021-06-30655000000 USD20220801Open filing evidence
2021-01-01 – 2021-06-301264000000 USD20220801Open filing evidence
2021-01-01 – 2021-03-31609000000 RestatedUSD20220504Open filing evidence
2020-04-01 – 2020-06-30685000000 USD20200805Open filing evidence
2020-01-01 – 2020-06-301507000000 USD20200805Open filing evidence
2020-01-01 – 2020-03-31822000000 USD20210503Open filing evidence
2019-07-01 – 2019-09-30832000000 USD2019-11-01 · 18:58:02.000ZOpen filing evidence
2019-01-01 – 2019-09-302510000000 USD2019-11-01 · 18:58:02.000ZOpen filing evidence
2019-04-01 – 2019-06-30823000000 USD20200805Open filing evidence
2019-01-01 – 2019-06-301678000000 USD20200805Open filing evidence
2019-01-01 – 2019-03-31855000000 USD2019-05-03 · 12:49:56.000ZOpen filing evidence
2018-07-01 – 2018-09-30915000000 USD2019-11-01 · 18:58:02.000ZOpen filing evidence
2018-01-01 – 2018-09-302796000000 USD2019-11-01 · 18:58:02.000ZOpen filing evidence
2018-04-01 – 2018-06-30942000000 USD2019-08-06 · 19:09:03.000ZOpen filing evidence
2018-01-01 – 2018-06-301881000000 USD2019-08-06 · 19:09:03.000ZOpen filing evidence
2018-01-01 – 2018-03-31939000000 USD2019-05-03 · 12:49:56.000ZOpen filing evidence
2017-07-01 – 2017-09-30886000000 USD20181029Open filing evidence
2017-01-01 – 2017-09-302489000000 USD20181029Open filing evidence
2017-04-01 – 2017-06-30830000000 USD20180803Open filing evidence
2017-01-01 – 2017-06-301603000000 USD20180803Open filing evidence

Operating Segments · Advanced Materials

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=emn:AdvancedMaterialsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30817000000 USD20260731Open filing evidence
2026-01-01 – 2026-06-301532000000 USD20260731Open filing evidence
2026-01-01 – 2026-03-31715000000 USD20260501Open filing evidence
2025-01-01 – 2025-12-312880000000 USD20260213Open filing evidence
2025-07-01 – 2025-09-30728000000 USD20251104Open filing evidence
2025-01-01 – 2025-09-302224000000 USD20251104Open filing evidence
2025-04-01 – 2025-06-30777000000 USD20260731Open filing evidence
2025-01-01 – 2025-06-301496000000 USD20260731Open filing evidence
2025-01-01 – 2025-03-31719000000 USD20260501Open filing evidence
2024-01-01 – 2024-12-313050000000 USD20260213Open filing evidence
2024-07-01 – 2024-09-30787000000 USD20251104Open filing evidence
2024-01-01 – 2024-09-302330000000 USD20251104Open filing evidence
2024-04-01 – 2024-06-30795000000 USD20250801Open filing evidence
2024-01-01 – 2024-06-301543000000 USD20250801Open filing evidence
2024-01-01 – 2024-03-31748000000 USD20250425Open filing evidence
2023-01-01 – 2023-12-312932000000 USD20260213Open filing evidence
2023-07-01 – 2023-09-30746000000 USD20241101Open filing evidence
2023-01-01 – 2023-09-302227000000 USD20241101Open filing evidence
2023-04-01 – 2023-06-30739000000 USD20240726Open filing evidence
2023-01-01 – 2023-06-301481000000 USD20240726Open filing evidence
2023-01-01 – 2023-03-31742000000 USD20230428Open filing evidence
2022-01-01 – 2022-12-313207000000 USD20250214Open filing evidence
2022-07-01 – 2022-09-30888000000 USD20221028Open filing evidence
2022-01-01 – 2022-09-302471000000 USD20221028Open filing evidence
2022-04-01 – 2022-06-30846000000 USD20230728Open filing evidence
2022-01-01 – 2022-06-301583000000 USD20230728Open filing evidence
2022-01-01 – 2022-03-31737000000 USD20230428Open filing evidence
2021-07-01 – 2021-09-30770000000 USD20221028Open filing evidence
2021-01-01 – 2021-09-302255000000 USD20221028Open filing evidence
2021-01-01 – 2021-03-31716000000 USD20220504Open filing evidence
2020-07-01 – 2020-09-30668000000 USD20201103Open filing evidence
2020-01-01 – 2020-09-301850000000 USD20201103Open filing evidence
2020-04-01 – 2020-06-30567000000 USD20200805Open filing evidence
2020-01-01 – 2020-06-301182000000 USD20200805Open filing evidence
2020-01-01 – 2020-03-31615000000 USD20210503Open filing evidence
2019-07-01 – 2019-09-30697000000 USD20201103Open filing evidence
2019-01-01 – 2019-09-302050000000 USD20201103Open filing evidence
2019-04-01 – 2019-06-30696000000 USD20200805Open filing evidence
2019-01-01 – 2019-06-301353000000 USD20200805Open filing evidence
2019-01-01 – 2019-03-31657000000 USD2019-05-03 · 12:49:56.000ZOpen filing evidence
2018-07-01 – 2018-09-30709000000 USD2019-11-01 · 18:58:02.000ZOpen filing evidence
2018-01-01 – 2018-09-302131000000 USD2019-11-01 · 18:58:02.000ZOpen filing evidence
2018-04-01 – 2018-06-30729000000 USD2019-08-06 · 19:09:03.000ZOpen filing evidence
2018-01-01 – 2018-06-301422000000 USD2019-08-06 · 19:09:03.000ZOpen filing evidence
2018-01-01 – 2018-03-31693000000 USD2019-05-03 · 12:49:56.000ZOpen filing evidence
2017-07-01 – 2017-09-30646000000 USD20181029Open filing evidence
2017-01-01 – 2017-09-301937000000 USD20181029Open filing evidence
2017-04-01 – 2017-06-30657000000 USD20180803Open filing evidence
2017-01-01 – 2017-06-301291000000 USD20180803Open filing evidence

Operating Segments · Chemical Intermediates

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=emn:ChemicalIntermediatesMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30643000000 USD20260731Open filing evidence
2026-01-01 – 2026-06-301138000000 USD20260731Open filing evidence
2026-01-01 – 2026-03-31495000000 USD20260501Open filing evidence
2025-01-01 – 2025-12-311925000000 USD20260213Open filing evidence
2025-07-01 – 2025-09-30499000000 USD20251104Open filing evidence
2025-01-01 – 2025-09-301507000000 USD20251104Open filing evidence
2025-04-01 – 2025-06-30463000000 USD20260731Open filing evidence
2025-01-01 – 2025-06-301008000000 USD20260731Open filing evidence
2025-01-01 – 2025-03-31545000000 USD20260501Open filing evidence
2024-01-01 – 2024-12-312134000000 USD20260213Open filing evidence
2024-07-01 – 2024-09-30593000000 USD20251104Open filing evidence
2024-01-01 – 2024-09-301631000000 USD20251104Open filing evidence
2024-04-01 – 2024-06-30515000000 USD20250801Open filing evidence
2024-01-01 – 2024-06-301038000000 USD20250801Open filing evidence
2024-01-01 – 2024-03-31523000000 USD20250425Open filing evidence
2023-01-01 – 2023-12-312143000000 USD20260213Open filing evidence
2023-07-01 – 2023-09-30527000000 USD20241101Open filing evidence
2023-01-01 – 2023-09-301630000000 USD20241101Open filing evidence
2023-04-01 – 2023-06-30514000000 USD20240726Open filing evidence
2023-01-01 – 2023-06-301103000000 USD20240726Open filing evidence
2023-01-01 – 2023-03-31589000000 USD20230428Open filing evidence
2022-01-01 – 2022-12-312716000000 USD20250214Open filing evidence
2022-07-01 – 2022-09-30665000000 RestatedUSD20231027Open filing evidence
2022-01-01 – 2022-09-302152000000 RestatedUSD20231027Open filing evidence
2022-04-01 – 2022-06-30772000000 RestatedUSD20230728Open filing evidence
2022-01-01 – 2022-06-301487000000 RestatedUSD20230728Open filing evidence
2022-01-01 – 2022-03-31715000000 USD20230428Open filing evidence
2021-07-01 – 2021-09-30731000000 USD20221028Open filing evidence
2021-01-01 – 2021-09-302072000000 USD20221028Open filing evidence
2021-04-01 – 2021-06-30736000000 USD20220801Open filing evidence
2021-01-01 – 2021-06-301341000000 USD20220801Open filing evidence
2021-01-01 – 2021-03-31605000000 USD20210503Open filing evidence
2020-04-01 – 2020-06-30461000000 USD20200805Open filing evidence
2020-01-01 – 2020-06-301053000000 USD20200805Open filing evidence
2020-01-01 – 2020-03-31592000000 USD20210503Open filing evidence
2019-07-01 – 2019-09-30579000000 USD2019-11-01 · 18:58:02.000ZOpen filing evidence
2019-01-01 – 2019-09-301865000000 USD2019-11-01 · 18:58:02.000ZOpen filing evidence
2019-04-01 – 2019-06-30631000000 USD20200805Open filing evidence
2019-01-01 – 2019-06-301286000000 USD20200805Open filing evidence
2019-01-01 – 2019-03-31655000000 USD2019-05-03 · 12:49:56.000ZOpen filing evidence
2018-07-01 – 2018-09-30703000000 USD2019-11-01 · 18:58:02.000ZOpen filing evidence
2018-01-01 – 2018-09-302142000000 USD2019-11-01 · 18:58:02.000ZOpen filing evidence
2018-04-01 – 2018-06-30709000000 USD2019-08-06 · 19:09:03.000ZOpen filing evidence
2018-01-01 – 2018-06-301439000000 USD2019-08-06 · 19:09:03.000ZOpen filing evidence
2018-01-01 – 2018-03-31730000000 USD2019-05-03 · 12:49:56.000ZOpen filing evidence
2017-07-01 – 2017-09-30696000000 USD20181029Open filing evidence
2017-01-01 – 2017-09-302069000000 USD20181029Open filing evidence
2017-04-01 – 2017-06-30703000000 USD20180803Open filing evidence
2017-01-01 – 2017-06-301373000000 USD20180803Open filing evidence

Operating Segments · Fibers

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=emn:FibersMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30243000000 USD20260731Open filing evidence
2026-01-01 – 2026-06-30468000000 USD20260731Open filing evidence
2026-01-01 – 2026-03-31225000000 USD20260501Open filing evidence
2025-01-01 – 2025-12-311050000000 USD20260213Open filing evidence
2025-07-01 – 2025-09-30254000000 USD20251104Open filing evidence
2025-01-01 – 2025-09-30816000000 USD20251104Open filing evidence
2025-04-01 – 2025-06-30274000000 USD20260731Open filing evidence
2025-01-01 – 2025-06-30562000000 USD20260731Open filing evidence
2025-01-01 – 2025-03-31288000000 USD20260501Open filing evidence
2024-01-01 – 2024-12-311318000000 USD20260213Open filing evidence
2024-07-01 – 2024-09-30336000000 USD20251104Open filing evidence
2024-01-01 – 2024-09-30997000000 USD20251104Open filing evidence
2024-04-01 – 2024-06-30330000000 USD20250801Open filing evidence
2024-01-01 – 2024-06-30661000000 USD20250801Open filing evidence
2024-01-01 – 2024-03-31331000000 USD20250425Open filing evidence
2023-01-01 – 2023-12-311295000000 USD20260213Open filing evidence
2023-07-01 – 2023-09-30323000000 USD20241101Open filing evidence
2023-01-01 – 2023-09-30949000000 USD20241101Open filing evidence
2023-04-01 – 2023-06-30323000000 USD20240726Open filing evidence
2023-01-01 – 2023-06-30626000000 USD20240726Open filing evidence
2023-01-01 – 2023-03-31303000000 USD20230428Open filing evidence
2022-01-01 – 2022-12-311022000000 USD20250214Open filing evidence
2022-07-01 – 2022-09-30250000000 USD20231027Open filing evidence
2022-01-01 – 2022-09-30705000000 USD20231027Open filing evidence
2022-04-01 – 2022-06-30242000000 USD20220801Open filing evidence
2022-01-01 – 2022-06-30455000000 USD20220801Open filing evidence
2022-01-01 – 2022-03-31213000000 USD20230428Open filing evidence
2021-07-01 – 2021-09-30222000000 USD20221028Open filing evidence
2021-01-01 – 2021-09-30662000000 USD20221028Open filing evidence
2021-04-01 – 2021-06-30223000000 USD20220801Open filing evidence
2021-01-01 – 2021-06-30440000000 USD20220801Open filing evidence
2021-01-01 – 2021-03-31217000000 USD20220504Open filing evidence
2020-07-01 – 2020-09-30206000000 USD20201103Open filing evidence
2020-01-01 – 2020-09-30629000000 USD20201103Open filing evidence
2020-04-01 – 2020-06-30211000000 USD20200805Open filing evidence
2020-01-01 – 2020-06-30423000000 USD20200805Open filing evidence
2020-01-01 – 2020-03-31212000000 USD20210503Open filing evidence
2019-07-01 – 2019-09-30217000000 USD20201103Open filing evidence
2019-01-01 – 2019-09-30643000000 USD20201103Open filing evidence
2019-04-01 – 2019-06-30213000000 USD20200805Open filing evidence
2019-01-01 – 2019-06-30426000000 USD20200805Open filing evidence
2019-01-01 – 2019-03-31213000000 USD20200511Open filing evidence
2018-07-01 – 2018-09-30220000000 USD2019-11-01 · 18:58:02.000ZOpen filing evidence
2018-01-01 – 2018-09-30706000000 USD2019-11-01 · 18:58:02.000ZOpen filing evidence
2018-04-01 – 2018-06-30241000000 USD2019-08-06 · 19:09:03.000ZOpen filing evidence
2018-01-01 – 2018-06-30486000000 USD2019-08-06 · 19:09:03.000ZOpen filing evidence
2018-01-01 – 2018-03-31245000000 USD2019-05-03 · 12:49:56.000ZOpen filing evidence
2017-07-01 – 2017-09-30224000000 USD20181029Open filing evidence
2017-01-01 – 2017-09-30652000000 USD20181029Open filing evidence
2017-04-01 – 2017-06-30215000000 USD20180803Open filing evidence
2017-01-01 – 2017-06-30428000000 USD20180803Open filing evidence

Operating Segments · Additives And Functional Products

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=emn:AdditivesAndFunctionalProductsMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-31939000000 USD20180507Open filing evidence
2017-07-01 – 2017-09-30886000000 USD20171102Open filing evidence
2017-01-01 – 2017-09-302489000000 USD20171102Open filing evidence
2017-04-01 – 2017-06-30830000000 USD20170804Open filing evidence
2017-01-01 – 2017-06-301603000000 USD20170804Open filing evidence
2017-01-01 – 2017-03-31773000000 USD20180507Open filing evidence
2016-07-01 – 2016-09-30752000000 USD20171102Open filing evidence
2016-01-01 – 2016-09-302259000000 USD20171102Open filing evidence
2016-04-01 – 2016-06-30770000000 USD20170804Open filing evidence
2016-01-01 – 2016-06-301507000000 USD20170804Open filing evidence
2016-01-01 – 2016-03-31737000000 USD20170505Open filing evidence
2015-07-01 – 2015-09-30794000000 RestatedUSD20161104Open filing evidence
2015-01-01 – 2015-09-302428000000 RestatedUSD20161104Open filing evidence
2015-04-01 – 2015-06-30830000000 RestatedUSD20160803Open filing evidence
2015-01-01 – 2015-06-301634000000 RestatedUSD20160803Open filing evidence
2015-01-01 – 2015-03-31804000000 RestatedUSD20160505Open filing evidence
2014-07-01 – 2014-09-30458000000 USD20151103Open filing evidence
2014-01-01 – 2014-09-301333000000 USD20151103Open filing evidence
2014-04-01 – 2014-06-30452000000 USD20150730Open filing evidence
2014-01-01 – 2014-06-30875000000 USD20150730Open filing evidence
2014-01-01 – 2014-03-31423000000 USD20150505Open filing evidence
2013-07-01 – 2013-09-30445000000 USD20141104Open filing evidence
2013-01-01 – 2013-09-301294000000 USD20141104Open filing evidence
2013-04-01 – 2013-06-30430000000 USD20140730Open filing evidence
2013-01-01 – 2013-06-30849000000 USD20140730Open filing evidence
2013-01-01 – 2013-03-31419000000 USD20140429Open filing evidence
2012-07-01 – 2012-09-30406000000 USD20131028Open filing evidence
2012-01-01 – 2012-09-30948000000 USD20131028Open filing evidence

Operating Segments · Adhesives And Plasticizers

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=emn:AdhesivesAndPlasticizersMember
PeriodValueUnitFiledEvidence
2015-07-01 – 2015-09-30305000000 USD20151103Open filing evidence
2015-01-01 – 2015-09-30942000000 USD20151103Open filing evidence
2015-04-01 – 2015-06-30317000000 USD20150730Open filing evidence
2015-01-01 – 2015-06-30637000000 USD20150730Open filing evidence
2015-01-01 – 2015-03-31320000000 USD20150505Open filing evidence
2014-07-01 – 2014-09-30347000000 USD20151103Open filing evidence
2014-01-01 – 2014-09-301050000000 USD20151103Open filing evidence
2014-04-01 – 2014-06-30358000000 USD20150730Open filing evidence
2014-01-01 – 2014-06-30703000000 USD20150730Open filing evidence
2014-01-01 – 2014-03-31345000000 USD20150505Open filing evidence
2013-07-01 – 2013-09-30321000000 USD20141104Open filing evidence
2013-01-01 – 2013-09-301005000000 USD20141104Open filing evidence
2013-04-01 – 2013-06-30339000000 USD20140730Open filing evidence
2013-01-01 – 2013-06-30684000000 USD20140730Open filing evidence
2013-01-01 – 2013-03-31345000000 USD20140429Open filing evidence
2012-07-01 – 2012-09-30348000000 USD20131028Open filing evidence
2012-01-01 – 2012-09-301094000000 USD20131028Open filing evidence

Operating Segments · Advanced Materials

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=emn:AdvancedMaterialsMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-31693000000 USD20180507Open filing evidence
2017-07-01 – 2017-09-30646000000 USD20171102Open filing evidence
2017-01-01 – 2017-09-301937000000 USD20171102Open filing evidence
2017-04-01 – 2017-06-30657000000 USD20170804Open filing evidence
2017-01-01 – 2017-06-301291000000 USD20170804Open filing evidence
2017-01-01 – 2017-03-31634000000 USD20180507Open filing evidence
2016-07-01 – 2016-09-30638000000 USD20171102Open filing evidence
2016-01-01 – 2016-09-301873000000 USD20171102Open filing evidence
2016-04-01 – 2016-06-30646000000 USD20170804Open filing evidence
2016-01-01 – 2016-06-301235000000 USD20170804Open filing evidence
2016-01-01 – 2016-03-31589000000 USD20170505Open filing evidence
2015-07-01 – 2015-09-30624000000 USD20161104Open filing evidence
2015-01-01 – 2015-09-301832000000 USD20161104Open filing evidence
2015-04-01 – 2015-06-30647000000 USD20160803Open filing evidence
2015-01-01 – 2015-06-301208000000 USD20160803Open filing evidence
2015-01-01 – 2015-03-31561000000 USD20160505Open filing evidence
2014-07-01 – 2014-09-30604000000 USD20151103Open filing evidence
2014-01-01 – 2014-09-301816000000 USD20151103Open filing evidence
2014-04-01 – 2014-06-30631000000 USD20150730Open filing evidence
2014-01-01 – 2014-06-301212000000 USD20150730Open filing evidence
2014-01-01 – 2014-03-31581000000 USD20150505Open filing evidence
2013-07-01 – 2013-09-30583000000 USD20141104Open filing evidence
2013-01-01 – 2013-09-301792000000 USD20141104Open filing evidence
2013-04-01 – 2013-06-30625000000 USD20140730Open filing evidence
2013-01-01 – 2013-06-301209000000 USD20140730Open filing evidence
2013-01-01 – 2013-03-31584000000 USD20140429Open filing evidence
2012-07-01 – 2012-09-30559000000 USD20131028Open filing evidence
2012-01-01 – 2012-09-301166000000 USD20131028Open filing evidence

Operating Segments · Chemical Intermediates

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=emn:ChemicalIntermediatesMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-31730000000 USD20180507Open filing evidence
2017-07-01 – 2017-09-30696000000 USD20171102Open filing evidence
2017-01-01 – 2017-09-302069000000 USD20171102Open filing evidence
2017-04-01 – 2017-06-30703000000 USD20170804Open filing evidence
2017-01-01 – 2017-06-301373000000 USD20170804Open filing evidence
2017-01-01 – 2017-03-31670000000 USD20180507Open filing evidence
2016-07-01 – 2016-09-30638000000 USD20171102Open filing evidence
2016-01-01 – 2016-09-301891000000 USD20171102Open filing evidence
2016-04-01 – 2016-06-30633000000 USD20170804Open filing evidence
2016-01-01 – 2016-06-301253000000 USD20170804Open filing evidence
2016-01-01 – 2016-03-31620000000 USD20170505Open filing evidence
2015-07-01 – 2015-09-30697000000 USD20161104Open filing evidence
2015-01-01 – 2015-09-302224000000 USD20161104Open filing evidence
2015-04-01 – 2015-06-30745000000 USD20160803Open filing evidence
2015-01-01 – 2015-06-301527000000 USD20160803Open filing evidence
2015-01-01 – 2015-03-31782000000 USD20160505Open filing evidence

Operating Segments · Fibers

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=emn:FibersMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-31245000000 USD20180507Open filing evidence
2017-07-01 – 2017-09-30224000000 USD20171102Open filing evidence
2017-01-01 – 2017-09-30652000000 USD20171102Open filing evidence
2017-04-01 – 2017-06-30215000000 USD20170804Open filing evidence
2017-01-01 – 2017-06-30428000000 USD20170804Open filing evidence
2017-01-01 – 2017-03-31213000000 USD20180507Open filing evidence
2016-07-01 – 2016-09-30248000000 USD20171102Open filing evidence
2016-01-01 – 2016-09-30762000000 USD20171102Open filing evidence
2016-04-01 – 2016-06-30234000000 USD20170804Open filing evidence
2016-01-01 – 2016-06-30514000000 USD20170804Open filing evidence
2016-01-01 – 2016-03-31280000000 USD20170505Open filing evidence
2015-07-01 – 2015-09-30320000000 USD20161104Open filing evidence
2015-01-01 – 2015-09-30903000000 USD20161104Open filing evidence
2015-04-01 – 2015-06-30299000000 USD20160803Open filing evidence
2015-01-01 – 2015-06-30583000000 USD20160803Open filing evidence
2015-01-01 – 2015-03-31284000000 USD20160505Open filing evidence
2014-07-01 – 2014-09-30346000000 USD20151103Open filing evidence
2014-01-01 – 2014-09-301086000000 USD20151103Open filing evidence
2014-04-01 – 2014-06-30386000000 USD20150730Open filing evidence
2014-01-01 – 2014-06-30740000000 USD20150730Open filing evidence
2014-01-01 – 2014-03-31354000000 USD20150505Open filing evidence
2013-07-01 – 2013-09-30363000000 USD20141104Open filing evidence
2013-01-01 – 2013-09-301072000000 USD20141104Open filing evidence
2013-04-01 – 2013-06-30363000000 USD20140730Open filing evidence
2013-01-01 – 2013-06-30709000000 USD20140730Open filing evidence
2013-01-01 – 2013-03-31346000000 USD20140429Open filing evidence
2012-07-01 – 2012-09-30349000000 USD20131028Open filing evidence
2012-01-01 – 2012-09-30990000000 USD20131028Open filing evidence

Operating Segments · Specialty Fluids And Intermediates

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=emn:SpecialtyFluidsAndIntermediatesMember
PeriodValueUnitFiledEvidence
2015-07-01 – 2015-09-30584000000 USD20151103Open filing evidence
2015-01-01 – 2015-09-301883000000 USD20151103Open filing evidence
2015-04-01 – 2015-06-30642000000 USD20150730Open filing evidence
2015-01-01 – 2015-06-301299000000 USD20150730Open filing evidence
2015-01-01 – 2015-03-31657000000 USD20150505Open filing evidence
2014-07-01 – 2014-09-30650000000 USD20151103Open filing evidence
2014-01-01 – 2014-09-301884000000 USD20151103Open filing evidence
2014-04-01 – 2014-06-30633000000 USD20150730Open filing evidence
2014-01-01 – 2014-06-301234000000 USD20150730Open filing evidence
2014-01-01 – 2014-03-31601000000 USD20150505Open filing evidence
2013-07-01 – 2013-09-30620000000 USD20141104Open filing evidence
2013-01-01 – 2013-09-301904000000 USD20141104Open filing evidence
2013-04-01 – 2013-06-30677000000 USD20140730Open filing evidence
2013-01-01 – 2013-06-301284000000 USD20140730Open filing evidence
2013-01-01 – 2013-03-31607000000 USD20140429Open filing evidence
2012-07-01 – 2012-09-30592000000 USD20131028Open filing evidence
2012-01-01 – 2012-09-301728000000 USD20131028Open filing evidence

Calculated Under Revenue Guidance In Effect Before Topic606 · Additives And Functional Products

Initial Application Period Cumulative Effect Transition · Statement Business Segments

Source dimensions us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member;us-gaap:StatementBusinessSegmentsAxis=emn:AdditivesAndFunctionalProductsMember
PeriodValueUnitFiledEvidence
2018-10-01 – 2018-12-31853000000 USD20190227Open filing evidence
2018-01-01 – 2018-12-313642000000 USD20190227Open filing evidence
2018-07-01 – 2018-09-30914000000 USD20181029Open filing evidence
2018-01-01 – 2018-09-302789000000 USD20181029Open filing evidence
2018-04-01 – 2018-06-30933000000 USD20180803Open filing evidence
2018-01-01 – 2018-06-301875000000 USD20180803Open filing evidence
2018-01-01 – 2018-03-31942000000 USD20180507Open filing evidence

Calculated Under Revenue Guidance In Effect Before Topic606 · Advanced Materials

Initial Application Period Cumulative Effect Transition · Statement Business Segments

Source dimensions us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member;us-gaap:StatementBusinessSegmentsAxis=emn:AdvancedMaterialsMember
PeriodValueUnitFiledEvidence
2018-10-01 – 2018-12-31640000000 USD20190227Open filing evidence
2018-01-01 – 2018-12-312741000000 USD20190227Open filing evidence
2018-07-01 – 2018-09-30698000000 USD20181029Open filing evidence
2018-01-01 – 2018-09-302101000000 USD20181029Open filing evidence
2018-04-01 – 2018-06-30730000000 USD20180803Open filing evidence
2018-01-01 – 2018-06-301403000000 USD20180803Open filing evidence
2018-01-01 – 2018-03-31673000000 USD20180507Open filing evidence

Calculated Under Revenue Guidance In Effect Before Topic606 · Chemical Intermediates

Initial Application Period Cumulative Effect Transition · Statement Business Segments

Source dimensions us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member;us-gaap:StatementBusinessSegmentsAxis=emn:ChemicalIntermediatesMember
PeriodValueUnitFiledEvidence
2018-10-01 – 2018-12-31682000000 USD20190227Open filing evidence
2018-01-01 – 2018-12-312831000000 USD20190227Open filing evidence
2018-07-01 – 2018-09-30690000000 USD20181029Open filing evidence
2018-01-01 – 2018-09-302149000000 USD20181029Open filing evidence
2018-04-01 – 2018-06-30712000000 USD20180803Open filing evidence
2018-01-01 – 2018-06-301459000000 USD20180803Open filing evidence
2018-01-01 – 2018-03-31747000000 USD20180507Open filing evidence

Calculated Under Revenue Guidance In Effect Before Topic606 · Fibers

Initial Application Period Cumulative Effect Transition · Statement Business Segments

Source dimensions us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member;us-gaap:StatementBusinessSegmentsAxis=emn:FibersMember
PeriodValueUnitFiledEvidence
2018-10-01 – 2018-12-31212000000 USD20190227Open filing evidence
2018-01-01 – 2018-12-31894000000 USD20190227Open filing evidence
2018-07-01 – 2018-09-30226000000 USD20181029Open filing evidence
2018-01-01 – 2018-09-30682000000 USD20181029Open filing evidence
2018-04-01 – 2018-06-30241000000 USD20180803Open filing evidence
2018-01-01 – 2018-06-30456000000 USD20180803Open filing evidence
2018-01-01 – 2018-03-31215000000 USD20180507Open filing evidence

Difference Between Revenue Guidance In Effect Before And After Topic606 · Additives And Functional Products

Initial Application Period Cumulative Effect Transition · Statement Business Segments

Source dimensions us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member;us-gaap:StatementBusinessSegmentsAxis=emn:AdditivesAndFunctionalProductsMember
PeriodValueUnitFiledEvidence
2018-10-01 – 2018-12-31-2000000 USD20190227Open filing evidence
2018-01-01 – 2018-12-315000000 USD20190227Open filing evidence
2018-07-01 – 2018-09-30-1000000 USD20181029Open filing evidence
2018-01-01 – 2018-09-30-7000000 USD20181029Open filing evidence
2018-04-01 – 2018-06-30-9000000 USD20180803Open filing evidence
2018-01-01 – 2018-06-30-6000000 USD20180803Open filing evidence
2018-01-01 – 2018-03-313000000 USD20180507Open filing evidence

Difference Between Revenue Guidance In Effect Before And After Topic606 · Advanced Materials

Initial Application Period Cumulative Effect Transition · Statement Business Segments

Source dimensions us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member;us-gaap:StatementBusinessSegmentsAxis=emn:AdvancedMaterialsMember
PeriodValueUnitFiledEvidence
2018-10-01 – 2018-12-31-16000000 USD20190227Open filing evidence
2018-01-01 – 2018-12-3114000000 USD20190227Open filing evidence
2018-07-01 – 2018-09-30-11000000 USD20181029Open filing evidence
2018-01-01 – 2018-09-30-30000000 USD20181029Open filing evidence
2018-04-01 – 2018-06-301000000 USD20180803Open filing evidence
2018-01-01 – 2018-06-30-19000000 USD20180803Open filing evidence
2018-01-01 – 2018-03-31-20000000 USD20180507Open filing evidence

Difference Between Revenue Guidance In Effect Before And After Topic606 · Chemical Intermediates

Initial Application Period Cumulative Effect Transition · Statement Business Segments

Source dimensions us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member;us-gaap:StatementBusinessSegmentsAxis=emn:ChemicalIntermediatesMember
PeriodValueUnitFiledEvidence
2018-10-01 – 2018-12-317000000 USD20190227Open filing evidence
2018-01-01 – 2018-12-310 USD20190227Open filing evidence
2018-07-01 – 2018-09-30-13000000 USD20181029Open filing evidence
2018-01-01 – 2018-09-307000000 USD20181029Open filing evidence
2018-04-01 – 2018-06-303000000 USD20180803Open filing evidence
2018-01-01 – 2018-06-3020000000 USD20180803Open filing evidence
2018-01-01 – 2018-03-3117000000 USD20180507Open filing evidence

Difference Between Revenue Guidance In Effect Before And After Topic606 · Fibers

Initial Application Period Cumulative Effect Transition · Statement Business Segments

Source dimensions us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member;us-gaap:StatementBusinessSegmentsAxis=emn:FibersMember
PeriodValueUnitFiledEvidence
2018-10-01 – 2018-12-310 USD20190227Open filing evidence
2018-01-01 – 2018-12-3124000000 USD20190227Open filing evidence
2018-07-01 – 2018-09-306000000 USD20181029Open filing evidence
2018-01-01 – 2018-09-30-24000000 USD20181029Open filing evidence
2018-04-01 – 2018-06-300 USD20180803Open filing evidence
2018-01-01 – 2018-06-30-30000000 USD20180803Open filing evidence
2018-01-01 – 2018-03-31-30000000 USD20180507Open filing evidence

Additives And Functional Products

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=emn:AdditivesAndFunctionalProductsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-312880000000 USD20260213Open filing evidence
2024-01-01 – 2024-12-312862000000 USD20260213Open filing evidence
2023-01-01 – 2023-12-312834000000 USD20260213Open filing evidence
2022-01-01 – 2022-12-313475000000 RestatedUSD20250214Open filing evidence
2021-01-01 – 2021-12-312949000000 RestatedUSD20240214Open filing evidence
2020-01-01 – 2020-12-312095000000 RestatedUSD20230215Open filing evidence
2019-01-01 – 2019-12-313273000000 USD20220225Open filing evidence
2018-10-01 – 2018-12-31851000000 USD20190227Open filing evidence
2018-01-01 – 2018-12-313647000000 USD20210222Open filing evidence
2017-01-01 – 2017-12-313343000000 USD20200226Open filing evidence
2016-01-01 – 2016-12-312979000000 USD20190227Open filing evidence
2015-01-01 – 2015-12-313159000000 RestatedUSD20180301Open filing evidence
2014-01-01 – 2014-12-312640000000 RestatedUSD20170227Open filing evidence
2013-01-01 – 2013-12-311719000000 USD20160225Open filing evidence
2013-04-01 – 2013-06-30430000000 USD20130805Open filing evidence
2013-01-01 – 2013-06-30849000000 USD20130805Open filing evidence
2013-01-01 – 2013-03-31419000000 USD20130430Open filing evidence
2012-01-01 – 2012-12-311332000000 USD20150227Open filing evidence
2012-07-01 – 2012-09-30406000000 USD20121031Open filing evidence
2012-01-01 – 2012-09-30948000000 USD20121031Open filing evidence
2012-04-01 – 2012-06-30279000000 USD20130805Open filing evidence
2012-01-01 – 2012-06-30542000000 USD20130805Open filing evidence
2012-01-01 – 2012-03-31263000000 USD20130430Open filing evidence
2011-01-01 – 2011-12-311067000000 USD20140228Open filing evidence
2011-07-01 – 2011-09-30262000000 USD20121031Open filing evidence
2011-01-01 – 2011-09-30822000000 USD20121031Open filing evidence
2010-01-01 – 2010-12-31931000000 USD20130228Open filing evidence

Additives And Functional Products · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=emn:AdditivesAndFunctionalProductsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30784000000 USD20261030Open filing evidence
2026-01-01 – 2026-09-302330000000 USD20261030Open filing evidence
2025-07-01 – 2025-09-30716000000 USD20261030Open filing evidence
2025-01-01 – 2025-09-302218000000 USD20261030Open filing evidence
2024-01-01 – 2024-03-31704000000 USD20240426Open filing evidence
2023-07-01 – 2023-09-30670000000 USD20231027Open filing evidence
2023-01-01 – 2023-09-302194000000 USD20231027Open filing evidence
2023-01-01 – 2023-03-31777000000 USD20240426Open filing evidence
2022-07-01 – 2022-09-30906000000 RestatedUSD20231027Open filing evidence
2022-01-01 – 2022-09-302719000000 RestatedUSD20231027Open filing evidence
2021-07-01 – 2021-09-30729000000 RestatedUSD20221028Open filing evidence
2021-01-01 – 2021-09-301993000000 RestatedUSD20221028Open filing evidence
2021-04-01 – 2021-06-30925000000 USD20210803Open filing evidence
2021-01-01 – 2021-06-301796000000 USD20210803Open filing evidence
2020-07-01 – 2020-09-30742000000 USD20211101Open filing evidence
2020-01-01 – 2020-09-302249000000 USD20211101Open filing evidence
2020-04-01 – 2020-06-30685000000 USD20210803Open filing evidence
2020-01-01 – 2020-06-301507000000 USD20210803Open filing evidence
2020-01-01 – 2020-03-31822000000 USD20200511Open filing evidence
2019-07-01 – 2019-09-30832000000 USD20201103Open filing evidence
2019-01-01 – 2019-09-302510000000 USD20201103Open filing evidence
2019-01-01 – 2019-03-31855000000 USD20200511Open filing evidence

Adhesives And Plasticizers

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=emn:AdhesivesAndPlasticizersMember
PeriodValueUnitFiledEvidence
2015-01-01 – 2015-12-311214000000 USD20160225Open filing evidence
2014-01-01 – 2014-12-311363000000 USD20160225Open filing evidence
2013-01-01 – 2013-12-311326000000 USD20160225Open filing evidence
2013-04-01 – 2013-06-30339000000 USD20130805Open filing evidence
2013-01-01 – 2013-06-30684000000 USD20130805Open filing evidence
2013-01-01 – 2013-03-31345000000 USD20130430Open filing evidence
2012-01-01 – 2012-12-311432000000 USD20150227Open filing evidence
2012-07-01 – 2012-09-30348000000 USD20121031Open filing evidence
2012-01-01 – 2012-09-301094000000 USD20121031Open filing evidence
2012-04-01 – 2012-06-30372000000 USD20130805Open filing evidence
2012-01-01 – 2012-06-30746000000 USD20130805Open filing evidence
2012-01-01 – 2012-03-31374000000 USD20130430Open filing evidence
2011-01-01 – 2011-12-311381000000 USD20140228Open filing evidence
2011-07-01 – 2011-09-30349000000 USD20121031Open filing evidence
2011-01-01 – 2011-09-301060000000 USD20121031Open filing evidence
2010-01-01 – 2010-12-311050000000 USD20130228Open filing evidence

Advanced Materials

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=emn:AdvancedMaterialsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-312880000000 USD20260213Open filing evidence
2024-01-01 – 2024-12-313050000000 USD20260213Open filing evidence
2023-01-01 – 2023-12-312932000000 USD20260213Open filing evidence
2022-01-01 – 2022-12-313207000000 USD20250214Open filing evidence
2021-01-01 – 2021-12-313027000000 USD20240214Open filing evidence
2020-01-01 – 2020-12-312524000000 USD20230215Open filing evidence
2019-01-01 – 2019-12-312688000000 USD20220225Open filing evidence
2018-10-01 – 2018-12-31624000000 USD20190227Open filing evidence
2018-01-01 – 2018-12-312755000000 USD20210222Open filing evidence
2017-01-01 – 2017-12-312572000000 USD20200226Open filing evidence
2016-01-01 – 2016-12-312457000000 USD20190227Open filing evidence
2015-01-01 – 2015-12-312414000000 USD20180301Open filing evidence
2014-01-01 – 2014-12-312378000000 USD20170227Open filing evidence
2013-01-01 – 2013-12-312349000000 USD20160225Open filing evidence
2013-04-01 – 2013-06-30625000000 USD20130805Open filing evidence
2013-01-01 – 2013-06-301209000000 USD20130805Open filing evidence
2013-01-01 – 2013-03-31584000000 USD20130430Open filing evidence
2012-01-01 – 2012-12-311694000000 USD20150227Open filing evidence
2012-07-01 – 2012-09-30559000000 USD20121031Open filing evidence
2012-01-01 – 2012-09-301166000000 USD20121031Open filing evidence
2012-04-01 – 2012-06-30315000000 USD20130805Open filing evidence
2012-01-01 – 2012-06-30607000000 USD20130805Open filing evidence
2012-01-01 – 2012-03-31292000000 USD20130430Open filing evidence
2011-01-01 – 2011-12-311195000000 USD20140228Open filing evidence
2011-07-01 – 2011-09-30278000000 USD20121031Open filing evidence
2011-01-01 – 2011-09-30918000000 USD20121031Open filing evidence
2010-01-01 – 2010-12-311043000000 USD20130228Open filing evidence

Advanced Materials · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=emn:AdvancedMaterialsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30762000000 USD20261030Open filing evidence
2026-01-01 – 2026-09-302294000000 USD20261030Open filing evidence
2025-07-01 – 2025-09-30728000000 USD20261030Open filing evidence
2025-01-01 – 2025-09-302224000000 USD20261030Open filing evidence
2024-01-01 – 2024-03-31748000000 USD20240426Open filing evidence
2023-07-01 – 2023-09-30746000000 USD20231027Open filing evidence
2023-01-01 – 2023-09-302227000000 USD20231027Open filing evidence
2023-01-01 – 2023-03-31742000000 USD20240426Open filing evidence
2022-07-01 – 2022-09-30888000000 USD20231027Open filing evidence
2022-01-01 – 2022-09-302471000000 USD20231027Open filing evidence
2022-04-01 – 2022-06-30846000000 USD20220801Open filing evidence
2022-01-01 – 2022-06-301583000000 USD20220801Open filing evidence
2021-07-01 – 2021-09-30770000000 USD20211101Open filing evidence
2021-01-01 – 2021-09-302255000000 USD20211101Open filing evidence
2021-04-01 – 2021-06-30769000000 USD20220801Open filing evidence
2021-01-01 – 2021-06-301485000000 USD20220801Open filing evidence
2020-07-01 – 2020-09-30668000000 USD20211101Open filing evidence
2020-01-01 – 2020-09-301850000000 USD20211101Open filing evidence
2020-04-01 – 2020-06-30567000000 USD20210803Open filing evidence
2020-01-01 – 2020-06-301182000000 USD20210803Open filing evidence
2020-01-01 – 2020-03-31615000000 USD20200511Open filing evidence
2019-01-01 – 2019-03-31657000000 USD20200511Open filing evidence

All Operating Segments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=emn:AllOperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-3110420000000 USD20230215Open filing evidence
2021-01-01 – 2021-12-319484000000 USD20230215Open filing evidence
2020-01-01 – 2020-12-317546000000 USD20230215Open filing evidence
2019-01-01 – 2019-12-319273000000 USD20200226Open filing evidence
2018-01-01 – 2018-12-3110151000000 USD20200226Open filing evidence
2017-01-01 – 2017-12-319495000000 USD20200226Open filing evidence
2016-01-01 – 2016-12-318962000000 USD20190227Open filing evidence
2015-01-01 – 2015-12-319603000000 USD20180301Open filing evidence
2014-01-01 – 2014-12-319509000000 USD20170227Open filing evidence
2013-01-01 – 2013-12-319332000000 USD20160225Open filing evidence
2012-01-01 – 2012-12-318091000000 USD20150227Open filing evidence
2012-07-01 – 2012-09-302254000000 USD20121031Open filing evidence
2012-01-01 – 2012-09-305926000000 USD20121031Open filing evidence
2012-04-01 – 2012-06-301851000000 u00020120802Open filing evidence
2012-01-01 – 2012-06-303672000000 u00020120802Open filing evidence
2011-01-01 – 2011-12-317178000000 USD20140228Open filing evidence
2011-07-01 – 2011-09-301812000000 USD20121031Open filing evidence
2011-01-01 – 2011-09-305455000000 USD20121031Open filing evidence
2011-04-01 – 2011-06-301885000000 u00020120802Open filing evidence
2011-01-01 – 2011-06-303643000000 u00020120802Open filing evidence
2010-01-01 – 2010-12-315842000000 USD20130228Open filing evidence

Caspi

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=emn:CaspiMember
PeriodValueUnitFiledEvidence
2012-04-01 – 2012-06-30486000000 u00020120802Open filing evidence
2012-01-01 – 2012-06-30956000000 u00020120802Open filing evidence
2012-01-01 – 2012-03-31470000000 u00020120510Open filing evidence
2011-04-01 – 2011-06-30491000000 u00020120802Open filing evidence
2011-01-01 – 2011-06-30958000000 u00020120802Open filing evidence
2011-01-01 – 2011-03-31467000000 u00020120510Open filing evidence

Chemical Intermediates

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=emn:ChemicalIntermediatesMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-311925000000 USD20260213Open filing evidence
2024-01-01 – 2024-12-312134000000 USD20260213Open filing evidence
2023-01-01 – 2023-12-312143000000 USD20260213Open filing evidence
2022-01-01 – 2022-12-312716000000 RestatedUSD20250214Open filing evidence
2021-01-01 – 2021-12-312608000000 RestatedUSD20240214Open filing evidence
2020-01-01 – 2020-12-312090000000 USD20230215Open filing evidence
2019-01-01 – 2019-12-312443000000 USD20220225Open filing evidence
2018-10-01 – 2018-12-31689000000 USD20190227Open filing evidence
2018-01-01 – 2018-12-312831000000 USD20210222Open filing evidence
2017-01-01 – 2017-12-312728000000 USD20200226Open filing evidence
2016-01-01 – 2016-12-312534000000 USD20190227Open filing evidence
2015-01-01 – 2015-12-312811000000 USD20180301Open filing evidence
2014-01-01 – 2014-12-313034000000 USD20170227Open filing evidence

Chemical Intermediates · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=emn:ChemicalIntermediatesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30580000000 USD20261030Open filing evidence
2026-01-01 – 2026-09-301718000000 USD20261030Open filing evidence
2025-07-01 – 2025-09-30499000000 USD20261030Open filing evidence
2025-01-01 – 2025-09-301507000000 USD20261030Open filing evidence
2024-01-01 – 2024-03-31523000000 USD20240426Open filing evidence
2023-01-01 – 2023-03-31589000000 USD20240426Open filing evidence
2022-01-01 – 2022-03-31799000000 USD20220504Open filing evidence
2021-07-01 – 2021-09-30731000000 USD20211101Open filing evidence
2021-01-01 – 2021-09-302072000000 USD20211101Open filing evidence
2021-04-01 – 2021-06-30736000000 USD20210803Open filing evidence
2021-01-01 – 2021-06-301341000000 USD20210803Open filing evidence
2021-01-01 – 2021-03-31605000000 USD20220504Open filing evidence
2020-07-01 – 2020-09-30506000000 USD20211101Open filing evidence
2020-01-01 – 2020-09-301559000000 USD20211101Open filing evidence
2020-04-01 – 2020-06-30461000000 USD20210803Open filing evidence
2020-01-01 – 2020-06-301053000000 USD20210803Open filing evidence
2020-01-01 – 2020-03-31592000000 USD20200511Open filing evidence
2019-07-01 – 2019-09-30579000000 USD20201103Open filing evidence
2019-01-01 – 2019-09-301865000000 USD20201103Open filing evidence
2019-01-01 – 2019-03-31655000000 USD20200511Open filing evidence

Fibers

Statement Business Segments

Multiple units reported for the same period; values are kept separate.

Source dimensions us-gaap:StatementBusinessSegmentsAxis=emn:FibersMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-311050000000 USD20260213Open filing evidence
2024-01-01 – 2024-12-311318000000 USD20260213Open filing evidence
2023-01-01 – 2023-12-311295000000 USD20260213Open filing evidence
2022-01-01 – 2022-12-311022000000 USD20250214Open filing evidence
2021-01-01 – 2021-12-31900000000 USD20240214Open filing evidence
2020-01-01 – 2020-12-31837000000 USD20230215Open filing evidence
2019-01-01 – 2019-12-31869000000 USD20220225Open filing evidence
2018-10-01 – 2018-12-31212000000 USD20190227Open filing evidence
2018-01-01 – 2018-12-31918000000 USD20210222Open filing evidence
2017-01-01 – 2017-12-31852000000 USD20200226Open filing evidence
2016-01-01 – 2016-12-31992000000 USD20190227Open filing evidence
2015-01-01 – 2015-12-311219000000 USD20180301Open filing evidence
2014-01-01 – 2014-12-311457000000 USD20170227Open filing evidence
2013-01-01 – 2013-12-311441000000 USD20160225Open filing evidence
2013-04-01 – 2013-06-30363000000 USD20130805Open filing evidence
2013-01-01 – 2013-06-30709000000 USD20130805Open filing evidence
2013-01-01 – 2013-03-31346000000 USD20130430Open filing evidence
2012-01-01 – 2012-12-311315000000 USD20150227Open filing evidence
2012-07-01 – 2012-09-30349000000 USD20121031Open filing evidence
2012-01-01 – 2012-09-30990000000 USD20121031Open filing evidence
2012-04-01 – 2012-06-30318000000 u00020120802Open filing evidence
2012-04-01 – 2012-06-30318000000 USD20130805Open filing evidence
2012-01-01 – 2012-06-30641000000 u00020120802Open filing evidence
2012-01-01 – 2012-06-30641000000 USD20130805Open filing evidence
2012-01-01 – 2012-03-31323000000 u00020120510Open filing evidence
2012-01-01 – 2012-03-31323000000 USD20130430Open filing evidence
2011-01-01 – 2011-12-311279000000 USD20140228Open filing evidence
2011-07-01 – 2011-09-30334000000 USD20121031Open filing evidence
2011-01-01 – 2011-09-30955000000 USD20121031Open filing evidence
2011-04-01 – 2011-06-30331000000 u00020120802Open filing evidence
2011-01-01 – 2011-06-30621000000 u00020120802Open filing evidence
2011-01-01 – 2011-03-31290000000 u00020120510Open filing evidence
2010-01-01 – 2010-12-311142000000 USD20130228Open filing evidence

Fibers · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=emn:FibersMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30255000000 USD20261030Open filing evidence
2026-01-01 – 2026-09-30723000000 USD20261030Open filing evidence
2025-07-01 – 2025-09-30254000000 USD20261030Open filing evidence
2025-01-01 – 2025-09-30816000000 USD20261030Open filing evidence
2024-01-01 – 2024-03-31331000000 USD20240426Open filing evidence
2023-04-01 – 2023-06-30323000000 USD20230728Open filing evidence
2023-01-01 – 2023-06-30626000000 USD20230728Open filing evidence
2023-01-01 – 2023-03-31303000000 USD20240426Open filing evidence
2022-04-01 – 2022-06-30242000000 USD20230728Open filing evidence
2022-01-01 – 2022-06-30455000000 USD20230728Open filing evidence
2021-07-01 – 2021-09-30222000000 USD20211101Open filing evidence
2021-01-01 – 2021-09-30662000000 USD20211101Open filing evidence
2021-04-01 – 2021-06-30223000000 USD20210803Open filing evidence
2021-01-01 – 2021-06-30440000000 USD20210803Open filing evidence
2020-07-01 – 2020-09-30206000000 USD20211101Open filing evidence
2020-01-01 – 2020-09-30629000000 USD20211101Open filing evidence
2020-04-01 – 2020-06-30211000000 USD20210803Open filing evidence
2020-01-01 – 2020-06-30423000000 USD20210803Open filing evidence

Pci

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=emn:PciMember
PeriodValueUnitFiledEvidence
2012-04-01 – 2012-06-30732000000 u00020120802Open filing evidence
2012-01-01 – 2012-06-301468000000 u00020120802Open filing evidence
2012-01-01 – 2012-03-31736000000 u00020120510Open filing evidence
2011-04-01 – 2011-06-30729000000 u00020120802Open filing evidence
2011-01-01 – 2011-06-301423000000 u00020120802Open filing evidence
2011-01-01 – 2011-03-31694000000 u00020120510Open filing evidence

Specialty Fluids And Intermediates

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=emn:SpecialtyFluidsAndIntermediatesMember
PeriodValueUnitFiledEvidence
2015-01-01 – 2015-12-312388000000 USD20160225Open filing evidence
2014-01-01 – 2014-12-312490000000 USD20160225Open filing evidence
2013-01-01 – 2013-12-312497000000 USD20160225Open filing evidence
2013-04-01 – 2013-06-30677000000 USD20130805Open filing evidence
2013-01-01 – 2013-06-301284000000 USD20130805Open filing evidence
2013-01-01 – 2013-03-31607000000 USD20130430Open filing evidence
2012-01-01 – 2012-12-312318000000 USD20150227Open filing evidence
2012-07-01 – 2012-09-30592000000 USD20121031Open filing evidence
2012-01-01 – 2012-09-301728000000 USD20121031Open filing evidence
2012-04-01 – 2012-06-30567000000 USD20130805Open filing evidence
2012-01-01 – 2012-06-301136000000 USD20130805Open filing evidence
2012-01-01 – 2012-03-31569000000 USD20130430Open filing evidence
2011-01-01 – 2011-12-312256000000 USD20140228Open filing evidence
2011-07-01 – 2011-09-30589000000 USD20121031Open filing evidence
2011-01-01 – 2011-09-301700000000 USD20121031Open filing evidence
2010-01-01 – 2010-12-311676000000 USD20130228Open filing evidence

Specialty Plastics

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=emn:SpecialtyPlasticsMember
PeriodValueUnitFiledEvidence
2012-04-01 – 2012-06-30315000000 u00020120802Open filing evidence
2012-01-01 – 2012-06-30607000000 u00020120802Open filing evidence
2012-01-01 – 2012-03-31292000000 u00020120510Open filing evidence
2011-04-01 – 2011-06-30334000000 u00020120802Open filing evidence
2011-01-01 – 2011-06-30641000000 u00020120802Open filing evidence
2011-01-01 – 2011-03-31307000000 u00020120510Open filing evidence

All Other Segments

Statement Business Segments

Multiple units reported for the same period; values are kept separate.

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-3117000000 USD20260213Open filing evidence
2024-01-01 – 2024-12-3118000000 USD20260213Open filing evidence
2023-01-01 – 2023-12-316000000 USD20260213Open filing evidence
2022-01-01 – 2022-12-31160000000 USD20250214Open filing evidence
2021-01-01 – 2021-12-31992000000 USD20240214Open filing evidence
2020-01-01 – 2020-12-31927000000 USD20230215Open filing evidence
2019-01-01 – 2019-12-310 USD20200226Open filing evidence
2018-01-01 – 2018-12-310 USD20200226Open filing evidence
2017-01-01 – 2017-12-3154000000 USD20200226Open filing evidence
2016-01-01 – 2016-12-3146000000 USD20190227Open filing evidence
2015-01-01 – 2015-12-3145000000 USD20180301Open filing evidence
2014-01-01 – 2014-12-3118000000 USD20170227Open filing evidence
2013-01-01 – 2013-12-3118000000 USD20160225Open filing evidence
2013-04-01 – 2013-06-306000000 USD20130805Open filing evidence
2013-01-01 – 2013-06-3012000000 USD20130805Open filing evidence
2013-01-01 – 2013-03-316000000 USD20130430Open filing evidence
2012-01-01 – 2012-12-3111000000 USD20150227Open filing evidence
2012-07-01 – 2012-09-305000000 USD20121031Open filing evidence
2012-01-01 – 2012-09-307000000 USD20121031Open filing evidence
2012-04-01 – 2012-06-302000000 u00020120802Open filing evidence
2012-04-01 – 2012-06-302000000 USD20130805Open filing evidence
2012-01-01 – 2012-06-302000000 u00020120802Open filing evidence
2012-01-01 – 2012-06-302000000 USD20130805Open filing evidence
2012-01-01 – 2012-03-310 USD20130430Open filing evidence
2011-01-01 – 2011-12-310 USD20140228Open filing evidence
2011-07-01 – 2011-09-300 USD20121031Open filing evidence
2011-01-01 – 2011-09-300 USD20121031Open filing evidence
2011-04-01 – 2011-06-300 u00020120802Open filing evidence
2011-01-01 – 2011-06-300 u00020120802Open filing evidence
2010-01-01 – 2010-12-310 USD20130228Open filing evidence

Reportable Segments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:ReportableSegmentsMember
PeriodValueUnitFiledEvidence
2013-04-01 – 2013-06-302434000000 USD20130805Open filing evidence
2013-01-01 – 2013-06-304735000000 USD20130805Open filing evidence
2013-01-01 – 2013-03-312301000000 USD20130430Open filing evidence
2012-04-01 – 2012-06-301851000000 USD20130805Open filing evidence
2012-01-01 – 2012-06-303672000000 USD20130805Open filing evidence
2012-01-01 – 2012-03-311821000000 USD20130430Open filing evidence